|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
61,650,000 |
Market
Cap: |
241.67(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.08 - $5.47 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Omeros is a commercial-stage biopharmaceutical company. Co. is focused on discovering, developing and commercializing small-molecule and protein therapeutics for larger-market as well as orphan indications targeting immunologic diseases. Co.'s drug candidate narsoplimab is the subject of a biologics license application pending before the U.S. Food and Drug Administration for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Co. has various late-stage clinical development programs in its pipeline, which are focused on: complement-mediated disorders, including immunoglobulin A nephropathy, atypical hemolytic uremic syndrome and COVID-19.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
25,000 |
25,000 |
Total Buy Value |
$0 |
$0 |
$40,500 |
$40,500 |
Total People Bought |
0 |
0 |
2 |
2 |
Total Buy Transactions |
0 |
0 |
2 |
2 |
Total Shares Sold |
0 |
0 |
0 |
10,000 |
Total Sell Value |
$0 |
$0 |
$0 |
$64,950 |
Total People Sold |
0 |
0 |
0 |
2 |
Total Sell Transactions |
0 |
0 |
0 |
2 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Jacobsen Michael A |
VP FINANCE AND CAO |
|
2021-02-19 |
4 |
AS |
$22.64 |
$226,400 |
D/D |
(10,000) |
14,000 |
|
- |
|
Jacobsen Michael A |
VP FINANCE AND CAO |
|
2021-02-19 |
4 |
OE |
$10.27 |
$102,700 |
D/D |
10,000 |
24,000 |
|
- |
|
Hood Leroy E. Md Phd |
|
|
2021-02-12 |
4 |
OE |
$4.53 |
$22,650 |
D/D |
5,000 |
74,390 |
|
- |
|
Jacobsen Michael A |
VP FINANCE AND CAO |
|
2021-02-10 |
4 |
AS |
$22.49 |
$42,731 |
D/D |
(1,900) |
14,000 |
|
- |
|
Jacobsen Michael A |
VP FINANCE AND CAO |
|
2021-02-10 |
4 |
OE |
$10.27 |
$19,513 |
D/D |
1,900 |
15,900 |
|
- |
|
Jacobsen Michael A |
VP FINANCE AND CAO |
|
2021-01-20 |
4 |
OE |
$9.37 |
$93,700 |
D/D |
10,000 |
14,000 |
|
- |
|
Jacobsen Michael A |
VP FINANCE AND CAO |
|
2021-01-19 |
4 |
AS |
$19.95 |
$189,525 |
D/D |
(9,500) |
4,000 |
|
- |
|
Cable Thomas J. |
|
|
2021-01-13 |
4 |
AS |
$16.97 |
$84,850 |
D/D |
(5,000) |
35,067 |
|
- |
|
Cable Thomas J. |
|
|
2021-01-13 |
4 |
OE |
$4.53 |
$22,650 |
D/D |
5,000 |
40,067 |
|
- |
|
Cable Thomas J. |
|
|
2020-05-13 |
4 |
AS |
$14.40 |
$71,999 |
D/D |
(5,000) |
35,067 |
|
- |
|
Cable Thomas J. |
|
|
2020-05-13 |
4 |
OE |
$5.92 |
$29,600 |
D/D |
5,000 |
40,067 |
|
- |
|
Hood Leroy E. Md Phd |
|
|
2020-03-13 |
4 |
OE |
$5.92 |
$29,600 |
D/D |
5,000 |
69,390 |
|
- |
|
Hood Leroy E. Md Phd |
Director |
|
2019-12-14 |
4 |
OE |
$7.56 |
$75,600 |
D/D |
10,000 |
64,390 |
|
- |
|
Demopulos Peter A Md |
Director |
|
2019-12-14 |
4 |
OE |
$7.56 |
$25,205 |
D/D |
3,334 |
188,516 |
|
- |
|
Cable Thomas J. |
Director |
|
2019-12-03 |
4 |
AS |
$14.41 |
$144,148 |
D/D |
(10,000) |
35,067 |
|
- |
|
Cable Thomas J. |
Director |
|
2019-12-03 |
4 |
OE |
$7.56 |
$75,600 |
D/D |
10,000 |
45,067 |
|
- |
|
Cable Thomas J. |
Director |
|
2019-10-14 |
4 |
AS |
$15.12 |
$75,590 |
D/D |
(5,000) |
35,067 |
|
- |
|
Cancelmo Peter B |
See RemarksOfficer |
|
2019-06-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
200 |
|
- |
|
Kelbon Marcia S. |
VP Patent and General Counsel |
|
2019-06-07 |
4 |
OE |
$6.05 |
$60,500 |
D/D |
10,000 |
210,645 |
|
- |
|
Kelbon Marcia S. |
VP Patent and General Counsel |
|
2018-08-31 |
4 |
OE |
$4.10 |
$79,269 |
D/D |
15,529 |
200,645 |
|
- |
|
Kelbon Marcia S. |
VP Patent and General Counsel |
|
2018-08-31 |
4 |
AS |
$25.31 |
$193,846 |
D/D |
(7,529) |
192,645 |
|
- |
|
Kelbon Marcia S. |
VP Patent and General Counsel |
|
2018-08-30 |
4 |
AS |
$24.45 |
$855,750 |
D/D |
(35,000) |
192,645 |
|
- |
|
Kelbon Marcia S. |
VP Patent and General Counsel |
|
2018-08-30 |
4 |
OE |
$4.10 |
$143,500 |
D/D |
35,000 |
227,645 |
|
- |
|
Kelbon Marcia S. |
VP Patent and General Counsel |
|
2018-07-27 |
4 |
AS |
$21.73 |
$124,357 |
D/D |
(5,723) |
192,645 |
|
- |
|
Kelbon Marcia S. |
VP Patent and General Counsel |
|
2018-07-27 |
4 |
OE |
$4.10 |
$23,464 |
D/D |
5,723 |
198,368 |
|
- |
|
123 Records found
|
|
Page 2 of 5 |
|
|